LEICX
Price
$23.09
Change
-$0.08 (-0.35%)
Updated
Jul 11 closing price
Net Assets
744.66M
RMEBX
Price
$59.72
Change
-$0.20 (-0.33%)
Updated
Jul 11 closing price
Net Assets
108.87B
Interact to see
Advertisement

LEICX vs RMEBX

Header iconLEICX vs RMEBX Comparison
Open Charts LEICX vs RMEBXBanner chart's image
Federated Hermes Equity Income C
Price$23.09
Change-$0.08 (-0.35%)
VolumeN/A
Net Assets744.66M
American Funds American Mutual R2E
Price$59.72
Change-$0.20 (-0.33%)
VolumeN/A
Net Assets108.87B
LEICX vs RMEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LEICX vs. RMEBX commentary
Jul 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LEICX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 109B vs. LEICX (745M). RMEBX pays higher dividends than LEICX: RMEBX (1.12) vs LEICX (0.25). LEICX was incepted earlier than RMEBX: LEICX (32 years) vs RMEBX (11 years). LEICX (1.92) is less costly to investors than RMEBX (1.07). LEICX is a more actively managed with annual turnover of: 74.00 vs. RMEBX (31.00). RMEBX has a lower initial minimum investment than LEICX: RMEBX (250) vs LEICX (1500). RMEBX annual gain was more profitable for investors over the last year : 9.65 vs. LEICX (-3.93). RMEBX return over 5 years is better than : 60.34 vs. LEICX (24.91).
LEICXRMEBXLEICX / RMEBX
Total Expense Ratio1.921.07179%
Annual Report Gross Expense Ratio1.921.07179%
Fund Existence32 years11 years-
Gain YTD6.9059.36674%
Front LoadN/AN/A-
Min. Initial Investment1500250600%
Min. Initial Investment IRAN/AN/A-
Net Assets745M109B1%
Annual Yield % from dividends0.251.1222%
Returns for 1 year-3.939.65-41%
Returns for 3 years11.2230.4637%
Returns for 5 years24.9160.3441%
Returns for 10 years1.6174.442%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLYM1.370.02
+1.48%
Climb Bio Inc
UDR40.40-0.09
-0.22%
UDR
APGE38.14-0.43
-1.11%
Apogee Therapeutics
MTW13.05-0.34
-2.54%
Manitowoc Company (The)
VERO2.62-0.11
-4.03%
Venus Concept